1 St Source Bank Dexcom Inc Transaction History

1 St Source Bank

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$114.22 - $140.1 $2,055 - $2,521	-18 Reduced 1.03%	1,732 $240,000
Q4 2023 Feb 08, 2024	BUY	$75.49 - $124.16 $132,107 - $217,280	1,750 New	1,750 $217,000
Q2 2023 Aug 09, 2023	SELL	$112.47 - $130.98 $7,647 - $8,906	-68 Reduced 3.58%	1,832 $235,000
Q1 2023 May 09, 2023	SELL	$104.0 - $122.92 $1,248 - $1,475	-12 Reduced 0.63%	1,900 $220,000
Q4 2022 Feb 13, 2023	BUY	$84.98 - $122.67 $162,481 - $234,545	1,912 New	1,912 $216,000
Q2 2022 Aug 05, 2022	SELL	$67.99 - $132.89 $32,499 - $63,521	-478 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$94.08 - $130.2 $1,599 - $2,213	17 Added 3.69%	478 $245,000
Q4 2021 Feb 09, 2022	SELL	$129.87 - $162.82 $1,298 - $1,628	-10 Reduced 2.12%	461 $248,000
Q2 2021 Aug 03, 2021	BUY	$80.99 - $107.93 $38,146 - $50,835	471 New	471 $201,000
Q4 2020 Feb 05, 2021	SELL	$78.0 - $104.5 $44,538 - $59,669	-571 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$62.68 - $105.34 $35,790 - $60,149	571 New	571 $231,000
Q4 2018 Feb 11, 2019	SELL	$26.99 - $37.37 $43,372 - $60,053	-1,607 Closed	0 $0
Q3 2018 Oct 31, 2018	BUY	$23.35 - $36.72 $37,523 - $59,009	1,607 New	1,607 $230,000

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of 1 St Source Bank, based on Form 13F filings with the SEC.

Stay updated on 1 St Source Bank with notifications on news.